STING1 and neoplasm: The STING agonists SHR1032 (96), SAProsomes-3 (93), diBSP01 (97), BSP16 (98), DMXAA (99), and ALG-031048 (100) all inhibit tumor growth through inhibiting activation of STING in colorectal cancer.